Literature DB >> 12655576

Mutation analysis in 16 patients with mtDNA depletion.

R Carrozzo1, B Bornstein, S Lucioli, Y Campos, P de la Pena, N Petit, C Dionisi-Vici, L Vilarinho, T Rizza, E Bertini, R Garesse, F M Santorelli, J Arenas.   

Abstract

Sixteen unrelated Southern European patients with the mitochondrial depletion syndrome (MDS) were analyzed for mutations in the TK2 and DGUOK genes. Three novel mutations were identified in TK2 (R183G, R254X, and 142insG). When we analyzed additional genes involved in the dNTPs pool, such as SLC25A19 (DNC) and NT5M (d-NT2), we did not detect mutations. The current study suggest that scanning the TK2, DGUOK, SLC25A19, and NT5M genes is likely to help about 10% of MDS families in terms of genetic counseling. Also, our findings indicate that genotype-phenotype correlations are not straightforward in MDS. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12655576     DOI: 10.1002/humu.9135

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  9 in total

Review 1.  Inherited mitochondrial diseases of DNA replication.

Authors:  William C Copeland
Journal:  Annu Rev Med       Date:  2008       Impact factor: 13.739

2.  Genes, patients, families, doctors-mutation analysis in clinical practice.

Authors:  J H Walter
Journal:  J Inherit Metab Dis       Date:  2009-03-24       Impact factor: 4.982

Review 3.  Defects in mitochondrial DNA replication and human disease.

Authors:  William C Copeland
Journal:  Crit Rev Biochem Mol Biol       Date:  2012 Jan-Feb       Impact factor: 8.250

4.  Over-expression of the catalytic core of mitochondrial DNA (mtDNA) polymerase in the nervous system of Drosophila melanogaster reduces median life span by inducing mtDNA depletion.

Authors:  Francisco Martínez-Azorín; Manuel Calleja; Rosana Hernández-Sierra; Carol L Farr; Laurie S Kaguni; Rafael Garesse
Journal:  J Neurochem       Date:  2007-11-12       Impact factor: 5.372

5.  Antiretroviral nucleosides, deoxynucleotide carrier and mitochondrial DNA: evidence supporting the DNA pol gamma hypothesis.

Authors:  William Lewis; James J Kohler; Seyed H Hosseini; Chad P Haase; William C Copeland; Rachelle J Bienstock; Tomika Ludaway; Jamie McNaught; Rodney Russ; Tami Stuart; Robert Santoianni
Journal:  AIDS       Date:  2006-03-21       Impact factor: 4.177

Review 6.  Advances in Thymidine Kinase 2 Deficiency: Clinical Aspects, Translational Progress, and Emerging Therapies.

Authors:  Andres Berardo; Cristina Domínguez-González; Kristin Engelstad; Michio Hirano
Journal:  J Neuromuscul Dis       Date:  2022

7.  Thymidine kinase 2 deficiency-induced mtDNA depletion in mouse liver leads to defect β-oxidation.

Authors:  Xiaoshan Zhou; Kristina Kannisto; Sophie Curbo; Ulrika von Döbeln; Kjell Hultenby; Sindra Isetun; Mats Gåfvels; Anna Karlsson
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

8.  Retrospective natural history of thymidine kinase 2 deficiency.

Authors:  Caterina Garone; Robert W Taylor; Andrés Nascimento; Joanna Poulton; Carl Fratter; Cristina Domínguez-González; Julie C Evans; Mariana Loos; Pirjo Isohanni; Anu Suomalainen; Dipak Ram; M Imelda Hughes; Robert McFarland; Emanuele Barca; Carlos Lopez Gomez; Sandeep Jayawant; Neil D Thomas; Adnan Y Manzur; Karin Kleinsteuber; Miguel A Martin; Timothy Kerr; Grainne S Gorman; Ewen W Sommerville; Patrick F Chinnery; Monika Hofer; Christoph Karch; Jeffrey Ralph; Yolanda Cámara; Marcos Madruga-Garrido; Jana Domínguez-Carral; Carlos Ortez; Sonia Emperador; Julio Montoya; Anupam Chakrapani; Joshua F Kriger; Robert Schoenaker; Bruce Levin; John L P Thompson; Yuelin Long; Shamima Rahman; Maria Alice Donati; Salvatore DiMauro; Michio Hirano
Journal:  J Med Genet       Date:  2018-03-30       Impact factor: 6.318

Review 9.  Structure, physiological role, and specific inhibitors of human thymidine kinase 2 (TK2): present and future.

Authors:  María-Jesús Pérez-Pérez; Eva-María Priego; Ana-Isabel Hernández; Olga Familiar; María-José Camarasa; Ana Negri; Federico Gago; Jan Balzarini
Journal:  Med Res Rev       Date:  2008-09       Impact factor: 12.944

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.